European Union
Regulator: Not represented
not_approved
As of: 9/9/2026 · Temporal status not established
Regulatory context incomplete: regulator.
Scientific intelligence record
Experience 2.0
Synthetic regulatory peptide
Synthetic tuftsin-derived heptapeptide studied primarily in Russian-language preclinical and clinical literature.
Record status
Traceability partial
Last meaningful update: 9/9/2026
Governed reviewed evidence
28
Governed records, not an efficacy score or total literature count.
Evidence boundary
0 / 28
Claim-linked support versus recorded evidence.
Research gaps
1
Unresolved questions remain visible.
Human experience
Below display gate
Observations never become clinical evidence.
Human experience · separate evidence stream
Eligible observations remain below the privacy and reliability threshold. WPF will not convert a handful of reports into a percentage, trend, or clinical claim.
Observation is valuable human context. It is not evidence of causation, efficacy, or safety.
Public display gate
n ≥ 20 eligible observations
Exact progress remains private before the threshold.
Intelligence snapshot
A compact view of what is represented, what remains unresolved, and how completely the record can be traced.
Governed reviewed evidence
28
Reviewed database records promoted through the governed publication workflow.
Contradictions
0
Conflicting evidence relationships that remain visible.
Research gaps
1
Questions the current record identifies as unresolved.
Connected media
0
Media records explicitly linked to this scientific record.
What we know
The project separates represented evidence from qualification, contradiction, uncertainty, and what the evidence does not establish.
This does not mean the scientific literature contains no findings. It means no reviewed institutional claim has been represented here.
Scientific context
Existing reviewed chemistry is preserved as scientific context. Chemistry and mechanism information do not establish clinical efficacy or safety.
Chemical identity describes the recorded molecular information. It does not establish biological activity, clinical efficacy, safety, or therapeutic suitability.
Explore further
Move from this peptide record into the project's broader evidence, research, comparison, and methodology systems.
Research
Chronology, unresolved research questions, opportunities, and researcher activity remain descriptive rather than evaluative.
2003 · study · Temporal status not established
Neuroscience and behavioral physiology
2006 · study · Temporal status not established
Bioorganicheskaia khimiia
2008 · study · Temporal status not established
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
2009 · study · Temporal status not established
Eksperimental'naia i klinicheskaia farmakologiia
Connections
Connections appear only when they are represented by the project’s underlying records.
institution
institution
institution
Traceability
The experience makes incomplete links visible instead of presenting a false impression of perfect provenance.
Source publication state
A governed source may be verified and approved for publication while its claim-to-evidence link is still incomplete.
Reviewer provenance state
“Human scientist reviewed: no” means that specific source-path attribution is not recorded. It does not silently negate the separate publication-review state.
Claim → Evidence
Incomplete
Evidence → Source
Connected
Source → Original record
Connected
Traceability documents how the project connects statements to records. It does not establish that a source is scientifically valid or that a claim is clinically true.
Incomplete links: claim-to-evidence
[A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders].
Observational archive
Observational archive data is intentionally separated from published scientific evidence.
Observational boundary
Insufficient eligible observations are available for display under the current filters.
Insufficient eligible observations are currently represented to display aggregated findings for this peptide.
Regulatory context
Regulatory status is jurisdiction-specific and time-dependent. It is presented as context, not as a recommendation for use or a substitute for scientific evidence evaluation.
European Union
Regulator: Not represented
As of: 9/9/2026 · Temporal status not established
Regulatory context incomplete: regulator.
United States
Regulator: Not represented
As of: 9/9/2026 · Temporal status not established
Regulatory context incomplete: regulator.
Research + media
Only media explicitly linked through the project’s relationship system appears here.
No scientifically connected media is currently represented for this peptide.
Sources + provenance
Selank evidence · ranking key
A tier describes the evidentiary role and design strength of a source. It is not a popularity score, proof that every conclusion is correct, or a substitute for claim-level review.
Large, well-conducted randomized trials; prespecified major outcomes; rigorous systematic reviews or meta-analyses; and major regulatory assessments.
Smaller randomized trials, strong prospective cohorts, prespecified secondary analyses, and high-quality comparative-effectiveness studies.
Retrospective cohorts, claims-database studies, pharmacovigilance analyses, mechanistic human research, and well-documented case series.
Case reports, conference abstracts, preclinical research, hypothesis-generating analyses, and expert commentary.
Tier classifies source design and evidentiary role. Confidence reflects risk of bias, sample size, comparator quality, outcome relevance, follow-up, missing data, directness, replication, reporting quality, and whether conclusions stay within the measured results.
Governed scientific evidence
Duplicate-safe scientific sources under accountable human review. Identified or pending records do not contribute as approved evidence.
Audit view
Human and preclinical evidence remain separate. Source identity, claim-to-source traceability, review dates, conflicts, limitations, and unknowns stay visible rather than being collapsed into one score.
PubMed-indexed clinical trial; comparative study; journal article examining [a comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders]. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article; review examining therapeutic peptides in orthopaedics: applications, challenges, and future directions. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article examining anticoagulant effects of arginine-containing peptides of the glyproline family (his-phe-arg-trp-pro-gly-pro and thr-lys-pro-arg-pro-gly-pro) revealed by thromboelastography. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article examining functional connectomic approach to studying selank and semax effects. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article; review examining tuftsin - properties and analogs. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article; research support, non-u.s. gov't examining the influence of selank on the level of cytokines under the conditions of "social" stress. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article examining the occurrence of putative cognitive enhancing research peptides in seized pharmaceutical preparations: an incentive for controlling agencies to prepare for future encounters of the kind. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article examining [experimental optimization of learning and memory processes by selank]. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed comparative study; journal article examining [immunomodulatory effects of selank in patients with anxiety-asthenic disorders]. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article examining [transcriptome alteration in hippocampus under the treatment of tuftsin analog selank]. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article examining selank administration affects the expression of some genes involved in gabaergic neurotransmission. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article examining peptide-based anxiolytics: the molecular aspects of heptapeptide selank biological activity. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article; research support, non-u.s. gov't examining the temporary dynamics of inflammation-related genes expression under tuftsin analog selank action. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed comparative study; journal article; research support, non-u.s. gov't examining the optimizing action of the synthetic peptide selank on a conditioned active avoidance reflex in rats. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article examining selank, peptide analogue of tuftsin, protects against ethanol-induced memory impairment by regulating of bdnf content in the hippocampus and prefrontal cortex in rats. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed comparative study; journal article examining [comparison of the effects of selank and tuftsin on the metabolism of serotonin in the brain of rats pretreated with pcpa]. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed english abstract; journal article; research support, non-u.s. gov't examining [effect of tripeptide pro-gly-pro on rat brain transcriptome in focal ischemia]. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article examining studying the toxic effects of some biologically active peptides on the model of mouse embryonic stem cells. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article examining state of colon microbiota in rats during chronic restraint stress and selank treatment. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article examining effect of selank on spontaneous synaptic activity of rat hippocampal ca1 neurons. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article examining morphological changes in the large intestine of rats subjected to chronic restraint stress and treated with selank. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed comparative study; journal article examining [comparison of pharmacological effects of heptapeptide selank after intranasal and intraperitoneal administration to balb/c and c57bl/6 mice.]. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article examining effect of selank on morphological parameters of rat liver in chronic foot-shock stress. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article; research support, non-u.s. gov't examining expression of inflammation-related genes in mouse spleen under tuftsin analog selank. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article examining peptide selank enhances the effect of diazepam in reducing anxiety in unpredictable chronic mild stress conditions in rats. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article examining effect of selank on functional state of rat hepatocytes under conditions of restraint stress. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article examining gaba, selank, and olanzapine affect the expression of genes involved in gabaergic neurotransmission in imr-32 cells. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article examining [evenly tritium-labeled peptides and their in vivo and in vitro biodegradation]. Machine-staged source candidate; findings and limitations require accountable review before publication.
2010 · study · Temporal status not established
Eksperimental'naia i klinicheskaia farmakologiia
2011 · study · Temporal status not established
Regulatory peptides
2013 · study · Temporal status not established
Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova
2014 · study · Temporal status not established
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
2014 · study · Temporal status not established
Molecular immunology
2014 · study · Temporal status not established
Molekuliarnaia biologiia
2016 · study · Temporal status not established
Frontiers in pharmacology
2016 · study · Temporal status not established
Eksperimental'naia i klinicheskaia farmakologiia
2017 · study · Temporal status not established
Bulletin of experimental biology and medicine
2017 · study · Temporal status not established
Current medicinal chemistry
2017 · study · Temporal status not established
Bulletin of experimental biology and medicine
2017 · study · Temporal status not established
Bulletin of experimental biology and medicine
2017 · study · Temporal status not established
Behavioural neurology
2017 · study · Temporal status not established
Bulletin of experimental biology and medicine
2017 · study · Temporal status not established
Frontiers in pharmacology
2018 · study · Temporal status not established
Protein and peptide letters
2019 · study · Temporal status not established
Bulletin of experimental biology and medicine
2019 · study · Temporal status not established
Bulletin of experimental biology and medicine
2019 · study · Temporal status not established
Bulletin of experimental biology and medicine
2020 · study · Temporal status not established
Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections
2020 · study · Temporal status not established
Drug testing and analysis
2020 · study · Temporal status not established
Bulletin of experimental biology and medicine
2021 · study · Temporal status not established
Current reviews in clinical and experimental pharmacology
2026 · study · Temporal status not established
Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews
2026 · regulatory · Temporal status not established
European Union
2026 · regulatory · Temporal status not established
United States
The represented chronology reflects records currently included in the governed dataset and does not claim to represent the entire scientific literature.
No institutional claim record is currently represented for this peptide.
Evidence is missing or not represented as studied; this is not a conclusion that the intervention does not work.
These are bibliographic author identities derived from represented records. Name strings are not proof of unique real-world researcher identity, and publishing organizations are not treated as institutional affiliations.
7 represented evidence records
Years represented: 2006, 2008, 2017, 2019, 2020
Publishing organizations appearing in records: Bioorganicheskaia khimiia, Bulletin of experimental biology and medicine, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
6 represented evidence records
Years represented: 2011, 2014, 2016, 2017, 2018
Publishing organizations appearing in records: Behavioural neurology, Frontiers in pharmacology, Molecular immunology, Protein and peptide letters, Regulatory peptides
5 represented evidence records
Years represented: 2011, 2014, 2016, 2017
Publishing organizations appearing in records: Behavioural neurology, Frontiers in pharmacology, Molecular immunology, Regulatory peptides
5 represented evidence records
Years represented: 2011, 2014, 2016, 2017
Publishing organizations appearing in records: Behavioural neurology, Frontiers in pharmacology, Molecular immunology, Regulatory peptides
5 represented evidence records
Years represented: 2011, 2014, 2016, 2017
Publishing organizations appearing in records: Behavioural neurology, Frontiers in pharmacology, Molecular immunology, Regulatory peptides
4 represented evidence records
Years represented: 2011, 2014, 2016, 2017
Publishing organizations appearing in records: Frontiers in pharmacology, Molecular immunology, Regulatory peptides
5 represented evidence records
Years represented: 2011, 2014, 2016, 2017
Publishing organizations appearing in records: Behavioural neurology, Frontiers in pharmacology, Molecular immunology, Regulatory peptides
4 represented evidence records
Years represented: 2017, 2019, 2020
Publishing organizations appearing in records: Bulletin of experimental biology and medicine
7 represented evidence records
Years represented: 2017, 2019, 2020
Publishing organizations appearing in records: Bulletin of experimental biology and medicine, Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections
3 represented evidence records
Years represented: 2006, 2014, 2020
Publishing organizations appearing in records: Bioorganicheskaia khimiia, Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
3 represented evidence records
Years represented: 2006, 2008, 2014
Publishing organizations appearing in records: Bioorganicheskaia khimiia, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
2 represented evidence records
Years represented: 2017, 2019
Publishing organizations appearing in records: Bulletin of experimental biology and medicine
institution
institution
institution
institution
institution
institution
institution
institution
institution
Claim: Not linked · Evidence: 2e5b5903-09ec-5d91-be49-ce15a5d476c1
PMID: 25176261 · DOI: Unavailable
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.
Claim: Not linked · Evidence: d363eb37-aa9f-55ef-b4fa-8aa02ae42424
PMID: 41490200 · DOI: 10.4155/fdd-2022-0009
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Anticoagulant Effects of Arginine-Containing Peptides of the Glyproline Family (His-Phe-Arg-Trp-Pro-Gly-Pro and Thr-Lys-Pro-Arg-Pro-Gly-Pro) Revealed by Thromboelastography.
Claim: Not linked · Evidence: 82ab788d-8157-5674-b606-e6546a2335dd
PMID: 29181670 · DOI: 10.1007/s10517-017-3950-4
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Functional Connectomic Approach to Studying Selank and Semax Effects.
Claim: Not linked · Evidence: 14af8785-4106-57b5-9ffc-2f1b749c8ee0
PMID: 32342318 · DOI: 10.1134/S001249662001007X
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Tuftsin - Properties and Analogs.
Claim: Not linked · Evidence: 7074d915-b153-59eb-8231-2b0f1d4b45c1
PMID: 28745220 · DOI: 10.2174/0929867324666170725140826
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
The Influence of Selank on the Level of Cytokines Under the Conditions of "Social" Stress.
Claim: Not linked · Evidence: 71ee25eb-c7cf-58fe-8625-10ca7c84ff0c
PMID: 32621722 · DOI: 10.2174/1574884715666200704152810
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
The occurrence of putative cognitive enhancing research peptides in seized pharmaceutical preparations: An incentive for controlling agencies to prepare for future encounters of the kind.
Claim: Not linked · Evidence: b9852b16-8678-5fbd-aae3-e927ab4af5c5
PMID: 31667971 · DOI: 10.1002/dta.2717
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
[Experimental optimization of learning and memory processes by selank].
Claim: Not linked · Evidence: 0e03c3cb-2432-55bd-815f-d5a4f53ce0a5
PMID: 20919548 · DOI: Unavailable
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
[Immunomodulatory effects of selank in patients with anxiety-asthenic disorders].
Claim: Not linked · Evidence: dceb75c9-50b3-5270-8248-f5514c911455
PMID: 18577961 · DOI: Unavailable
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
[Transcriptome alteration in hippocampus under the treatment of tuftsin analog Selank].
Claim: Not linked · Evidence: 681d6a24-36de-5005-a880-d07590c44c5a
PMID: 24450168 · DOI: 10.7868/s0044467713030052
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission.
Claim: Not linked · Evidence: 46b510bf-a90f-5d41-95e9-6142414bfe60
PMID: 26924987 · DOI: 10.1134/S1068162006020099
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity.
Claim: Not linked · Evidence: 94817d6b-88fb-58c0-a5ab-d296a1408bed
PMID: 30255741 · DOI: 10.2174/0929866525666180925144642
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
The temporary dynamics of inflammation-related genes expression under tuftsin analog Selank action.
Claim: Not linked · Evidence: 539064ce-f3b2-5da8-9df6-3be15e0209f5
PMID: 24291245 · DOI: 10.1016/j.molimm.2013.11.002
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
The optimizing action of the synthetic peptide Selank on a conditioned active avoidance reflex in rats.
Claim: Not linked · Evidence: af299365-23ef-594f-aa70-28a1158ec0c8
PMID: 14552529 · DOI: 10.1023/a:1024444321191
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats.
Claim: Not linked · Evidence: ca94c88c-cdea-5947-8342-772eb6434886
PMID: 31625062 · DOI: 10.1007/s10517-019-04588-9
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
[Comparison of the effects of selank and tuftsin on the metabolism of serotonin in the brain of rats pretreated with PCPA].
Claim: Not linked · Evidence: e50aa4be-a8e3-55a6-bfa8-0fee7fa780ad
PMID: 19803361 · DOI: Unavailable
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
[Effect of tripeptide Pro-Gly-Pro on rat brain transcriptome in focal ischemia].
Claim: Not linked · Evidence: 3090d6f0-95cd-5b7a-a466-617108551921
PMID: 25850296 · DOI: Unavailable
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Studying the Toxic Effects of Some Biologically Active Peptides on the Model of Mouse Embryonic Stem Cells.
Claim: Not linked · Evidence: c01f4515-7da3-5a14-81dd-494769b08529
PMID: 29063333 · DOI: 10.1007/s10517-017-3891-y
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
State of Colon Microbiota in Rats during Chronic Restraint Stress and Selank Treatment.
Claim: Not linked · Evidence: 384de40b-a19e-5b09-862e-10f0ea3e7405
PMID: 31236882 · DOI: 10.1007/s10517-019-04496-y
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Effect of Selank on Spontaneous Synaptic Activity of Rat Hippocampal CA1 Neurons.
Claim: Not linked · Evidence: 1183057d-fe24-5a47-a700-68b041d619b0
PMID: 28361410 · DOI: 10.1007/s10517-017-3676-3
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Morphological Changes in the Large Intestine of Rats Subjected to Chronic Restraint Stress and Treated with Selank.
Claim: Not linked · Evidence: 7f576a22-b53d-52b0-9622-7f57f2bd6941
PMID: 32651826 · DOI: 10.1007/s10517-020-04868-9
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
[COMPARISON OF PHARMACOLOGICAL EFFECTS OF HEPTAPEPTIDE SELANK AFTER INTRANASAL AND INTRAPERITONEAL ADMINISTRATION TO BALB/c AND C57BL/6 MICE.].
Claim: Not linked · Evidence: eb27ec05-dedd-56e6-bcba-7fb815d19aed
PMID: 29787664 · DOI: Unavailable
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Effect of Selank on Morphological Parameters of Rat Liver in Chronic Foot-Shock Stress.
Claim: Not linked · Evidence: 77a49e34-2b10-5d25-8457-8ccd71152346
PMID: 31243679 · DOI: 10.1007/s10517-019-04512-1
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Expression of inflammation-related genes in mouse spleen under tuftsin analog Selank.
Claim: Not linked · Evidence: ad24bb6f-ea40-5b9c-8f08-b7203ef71138
PMID: 21609736 · DOI: 10.1016/j.regpep.2011.05.001
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats.
Claim: Not linked · Evidence: 9d454780-bebf-5acf-8c7d-2b434e426001
PMID: 28280289 · DOI: 10.17116/jnevro20151156133-40
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Effect of Selank on Functional State of Rat Hepatocytes under Conditions of Restraint Stress.
Claim: Not linked · Evidence: b80b2286-7a29-50d3-8f2f-7f02344ef2ca
PMID: 28853100 · DOI: 10.1007/s10517-017-3817-8
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells.
Claim: Not linked · Evidence: f6bb7d64-19f4-52f9-8b01-5a958971f3ee
PMID: 28293190 · DOI: 10.1016/0014-2999(96)00066-0
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
[Evenly tritium-labeled peptides and their in vivo and in vitro biodegradation].
Claim: Not linked · Evidence: fa1fc14b-e6b1-5dbf-9adb-b55aed0de754
PMID: 16637290 · DOI: Unavailable
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Generated: 9/18/2026, 3:03:59 PM
Funding and conflicts are disclosed and considered, but sponsorship never automatically changes a tier. Corrections, retractions, and expressions of concern override the original rating.
Evidence searched through: Not recorded
Last accountable review: Not recorded
These are documentary and scientific-review signals, not conclusions of harm, ineffectiveness, safety, or absence of research.
This maturity index describes evidence-base development and governance. It is not a probability of efficacy, safety, truth, medical advice, or regulatory approval. Read the methodology.